Patents by Inventor Richard C. Thompson

Richard C. Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6569851
    Abstract: Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions that include a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: May 27, 2003
    Assignees: Elan Pharmaceutials, Inc., Eli Lilly & Company
    Inventors: Richard C. Thompson, Stephen Wilkie, Douglas R. Stack, Eldon E. VanMeter, Qing Shi, Thomas C. Britton, James E. Audia, Jon K. Reel, Thomas E. Mabry, Bruce A. Dressman, Cynthia L. Cwi, Steven S. Henry, Stacey L. McDaniel, Russell D. Stucky, Warren J. Porter
  • Patent number: 6552013
    Abstract: Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: April 22, 2003
    Assignees: Elan Pharmaceuticals, Inc., Eli Lilly and Company
    Inventors: James E. Audia, Warren J. Porter, Richard C. Thompson, Stephen C. Wilkie, Douglas R. Stack, Qing Shi
  • Publication number: 20030069445
    Abstract: Disclosed are biological reagents which comprise compounds that inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in determining the cellular mechanism involved in the generation of &bgr;-amyloid peptide.
    Type: Application
    Filed: August 14, 2002
    Publication date: April 10, 2003
    Inventors: James E. Audia, Paul A. Hyslop, Jeffrey S. Nissen, Richard C. Thompson, Jay S. Tung, Laura I. Tanner
  • Patent number: 6509331
    Abstract: Disclosed are compounds which inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits &bgr;-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.
    Type: Grant
    Filed: June 21, 1999
    Date of Patent: January 21, 2003
    Assignees: Elan Pharmaceuticals, Inc., Eli Lilly & Company
    Inventors: James E. Audia, Richard C. Thompson, Stephen C. Wilkie, Thomas C. Britton, Warren J. Porter, George W. Huffman, Lee H. Latimer
  • Patent number: 6486350
    Abstract: Disclosed are biological reagents which comprise compounds that inhibit &bgr;-amyloid peptide release and/or its synthesis, and, accordingly, have utility in determining the cellular mechanism involved in the generation of &bgr;-amyloid peptide.
    Type: Grant
    Filed: September 29, 1999
    Date of Patent: November 26, 2002
    Assignees: Elan Pharmaceuticals Inc., Eli Lilly & Company
    Inventors: James E. Audia, Paul A. Hyslop, Jeffrey S. Nissen, Richard C. Thompson, Jay S. Tung, Laura I. Tanner
  • Patent number: 6251945
    Abstract: A pharmaceutical mixture comprising a profen and one or more additional active compounds is described which has a total active compound content of over 85% and contains up to 1%, based on the content of the profen, of a nonionic surfactant having an HLB of ≧9 and a customary disintegrant and a lubricant.
    Type: Grant
    Filed: January 14, 1999
    Date of Patent: June 26, 2001
    Assignee: Knoll Aktiengesellschaft
    Inventors: Heinz Einig, Harald Hach, Raymond Eason, Bernd W. Müller, Richard C. Thompson
  • Patent number: 6037447
    Abstract: The present invention is directed to certain glycopeptide dimers in which two glycopeptide units are covalently linked to one another through their disaccharide amine, via a linking radical. This invention is also directed to the monomeric intermediates. All of these compounds are useful as antibacterials, especially for the control of gram positive bacteria; the compounds are particularly useful for the control of resistant bacterial strains, such as vancomycin-resistant-enterococci ("VRE").
    Type: Grant
    Filed: August 31, 1998
    Date of Patent: March 14, 2000
    Assignee: Eli Lilly and Company
    Inventors: Douglas R Stack, Richard C Thompson
  • Patent number: 5977062
    Abstract: The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity against a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.
    Type: Grant
    Filed: April 17, 1998
    Date of Patent: November 2, 1999
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Bret E. Huff, Thalia I. Nicas, John T. Quatroche, Michael J. Rodriguez, Nancy J. Snyder, Michael A. Staszak, Richard C. Thompson, Stephen C. Wilkie, Mark J. Zweifel
  • Patent number: 5843889
    Abstract: The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity aginst a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.
    Type: Grant
    Filed: March 12, 1997
    Date of Patent: December 1, 1998
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Bret E. Huff, Thalia I. Nicas, John T. Quatroche, Michael J. Rodriguez, Nancy J. Snyder, Michael A. Staszak, Richard C. Thompson, Stephen C. Wilkie, Mark J. Zweifel
  • Patent number: 5840684
    Abstract: The present invention provides glycopeptide antibiotic derivative compounds. These derivative compounds possess antibacterial activity against a wide variety of bacteria, including activity against vancomycin-resistant isolates. Methods of making and using these glycopeptide antibiotic derivative compounds are also provided.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: November 24, 1998
    Assignee: Eli Lilly and Company
    Inventors: Robin D. G. Cooper, Bret E. Huff, Thalia I. Nicas, John T. Quatroche, Michael J. Rodriguez, Nancy J. Snyder, Michael A. Staszak, Richard C. Thompson, Stephen C. Wilkie, Mark J. Zweifel
  • Patent number: 5710945
    Abstract: A camera mounting mechanism is attachable to a helicopter to support and isolate an exterior camera against vibrational forces generated by the helicopter during flight maneuvers.Individual shock absorbers are arranged in a ring pattern around a central axis of the mounting mechanism to absorb the vibrational forces.
    Type: Grant
    Filed: July 3, 1996
    Date of Patent: January 20, 1998
    Assignee: McMahon Helicopter Services, Inc.
    Inventor: Richard C. Thompson
  • Patent number: 5165365
    Abstract: A pet feeder includes a base, with a removable first and second tube structure arranged to capture a fluid container therebetween for means of replenishment and maintenance of the container in use. A feed dish is mounted upon an upper terminal end of the second tube. A modification of the invention includes replaceable weight members mounted within the base member for ease of disassembly of the structure during transport and storage of the organization.
    Type: Grant
    Filed: November 25, 1991
    Date of Patent: November 24, 1992
    Inventor: Richard C. Thompson
  • Patent number: 4627573
    Abstract: A pressure compensating flow control device includes a generally elongated, collapsible tubular body of flexible material such as silicone rubber having a teardrop shaped inlet orifice for extending into a high pressure supply line, an outlet end for distributing a flow of liquid with the inlet orifice and tubular body collapsible in response to pressure to maintain a generally predetermined uniform flow rate over a predetermined pressure range. The inlet end of the tubular member tapers down to a reduced teardrop inlet orifice with the outlet opening in one embodiment comprising a crescent shaped slit in the wall of the tube.
    Type: Grant
    Filed: February 17, 1984
    Date of Patent: December 9, 1986
    Assignee: Havens International
    Inventors: Glenn G. Havens, deceased, by Richard C. Thompson, executor